Efficacy and Safety of Nilotinib (NIL) vs Imatinib (IM) in Patients (pts) With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Long-Term Follow-Up (f/u) of ENESTnd - Richard A. Larson; Dong-Wook Kim; Surapol Issaragrilsil; Philipp le Coutre; Pedro Enrique Dorlhiac Llacer; Gabriel Etienne; Richard E. Clark; Ian Flinn; Hirohisa Nakamae; Andreas Hochhaus; Giuseppe Saglio; Hagop M. Kantarjian; et al. (Blood, 2014)